- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06245343
Investigation of the Effects of Functional Inspiratory Muscle Training in Patients With Lung Cancer
Investigation of the Effects of Functional Inspiratory Muscle Training on Oxygen Consumption, Muscle Oxygenation, Balance and Physical Activity Level in Patients With Lung Cancer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissues. The main treatment methods for lung cancer are chemotherapy, radiotherapy, and surgery. Molecularly targeted therapy and immunotherapy are also among the treatment options. Patients with lung cancer experience various symptoms such as dyspnea, cough, chest pain, hemoptysis, fatigue, weight loss due to the disease process, the effects of chemotherapy and radiotherapy treatment, and comorbidities. The treatment method varies depending on the histological type, stage, location of the tumor, and the physical condition of the patient. Surgery is performed as a therapeutic option for many patients with lung cancer. Lung cancer surgery impair the cardiorespiratory functions of the patients. Patients' pulmonary functions and diffusion capacity worsen following lung cancer surgery. In lung cancer patients, the incision applied to the respiratory muscles due to surgery and changes in the mechanics of the chest wall cause worsening of respiratory muscle function. The condition results in dyspnea in patients at rest and during activities of daily living. Mitochondrial dysfunction due to the pathogenesis of the disease and chemotherapy/radiotherapy leads to deterioration in muscle oxygen metabolism. In individuals with reduced muscle oxygen, exercise tolerance and muscle strength decrease. Impairment of diaphragm function is associated with decreased postural stability after lung cancer surgery. Patients with lung cancer have postural instability and balance problems. Lung cancer significantly affects the quality of life of patients, limiting their physical and social activities. Inspiratory muscle training is recommended as part of disease management for lung cancer. In the literature, there are studies investigating the effectiveness of inspiratory muscle training in lung cancer patients in the preoperative, perioperative, and postoperative periods. However, there is no study investigating functional inspiratory muscle training in patients with lung cancer. Functional inspiratory muscle training (IMT) was developed by McConnell. It is a program that is based on the functions of respiratory muscles other than breathing, and IMT is applied along with exercise.
The primary aim of this study: To investigate the effects of functional inspiratory muscle training on oxygen consumption, muscle oxygenation, balance and physical activity level in patients with lung cancer.
The secondary aim of this study: To investigate the effects of functional inspiratory muscle training on pulmonary functions, peripheral and respiratory muscle strength, inspiratory and trunk muscle endurance, cough strength, fatigue, dyspnea and quality of life in patients with lung cancer.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Meral BOŞNAK GÜÇLÜ, Prof. Dr.
- Phone Number: +903122162647
- Email: meralbosnak@gazi.edu.tr
Study Contact Backup
- Name: Gülsüm SERTTAŞ GÜVEN, MSc.
- Email: glsmserttas1@gmail.com
Study Locations
-
-
Çankaya
-
Ankara, Çankaya, Turkey (Türkiye), 06490
- Recruiting
- Gazi University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit
-
Contact:
- Meral BOŞNAK GÜÇLÜ, Prof. Dr.
- Phone Number: 0312 216 2647
- Email: meralbosnak@gazi.edu.tr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients aged 18-80 years with lung cancer
- Patients who have undergone surgical treatment (wedge resection, segmentectomy, lobectomy, bilobectomy) for lung cancer
- Lung cancer treatment completed, in remission and under follow-up
Exclusion Criteria:
- According to the American Association of Sports Medicine (ACSM) with absolute and relative contraindications to exercise tests
- Patients who are having comorbidities such as uncontrolled hypertension, diabetes mellitus, heart failure or atrial fibrillation
- Patients who are having acute infection during evaluation
- Patients who are having orthopedic, neurological, psychological, etc. problems that limit evaluations
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Functional inspiratory muscle training group
Patients in the training group will be performed functional inspiratory muscle training with the PowerBreathe® (inspiratory muscle training device) device at 50% of the maximal inspiratory pressure.
|
Patients will be given fundamental inspiratory muscle training with the inspiratory muscle training device at 50% of the maximal inspiratory pressure 30 min/day, 3 days/week for 4 weeks online with a physiotherapist. On the other days of the week, the training will be used as a home program. In the 5th week, the functional inspiratory muscle training program will be started. Before the program begins, patients will be shown the exercises in the functional inspiratory muscle training program. Patients will be given functional inspiratory muscle training with the inspiratory muscle training device at 50% of the maximal inspiratory pressure 30 min/day, 3 days/week for 4 weeks online with a physiotherapist. On the other days of the week, fundamental inspiratory muscle training will be used as a home program. Pressure increases will be made weekly to 10 centimeters of water (cmH2O). Unsupervised training sessions will be followed by charts filled out by patients. |
|
Sham Comparator: Control group
The control group will not be given any training during the study period.
|
The control group will not be given any training during the 8-week period.
After the study, the treatment applied to the training group will also be applied to the control group in order to ensure that the patients in the control group are not ethically deprived of rehabilitation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxygen Consumption
Time Frame: Trough study completion, an average of 2 year
|
Maximum exercise capacity will be assessed by symptom-limited cardiopulmonary exercise testing on a treadmill at gradually increasing speed and degree, and oxygen consumption will be measured during the test.
|
Trough study completion, an average of 2 year
|
|
Muscle oxygenation
Time Frame: Trough study completion, an average of 2 year
|
Muscle oxygenation of the quadriceps femoris (during the exercise test) and the diaphragm, scalene muscles, sternocleidomastoid muscle, and rectus abdominis muscle (at rest) will be assessed with a muscle oxygen monitor.
|
Trough study completion, an average of 2 year
|
|
Balance
Time Frame: Trough study completion, an average of 2 year
|
Balance will be evaluated using a balance assessment device.
|
Trough study completion, an average of 2 year
|
|
Balance (timed up and go test)
Time Frame: Trough study completion, an average of 2 year
|
Balance will be evaluated a timed up and go test.
|
Trough study completion, an average of 2 year
|
|
Physical activity level
Time Frame: Trough study completion, an average of 2 year
|
A multi-sensor activity monitor will be used to assess the level of physical activity.
|
Trough study completion, an average of 2 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cough Strength
Time Frame: Trough study completion, an average of 2 year
|
Cough strength will be assessed using a peak cough flow meter (PEFmeter) (ExpiRite Peak Flow Meter, China).
|
Trough study completion, an average of 2 year
|
|
Respiratory Muscle Strength
Time Frame: Trough study completion, an average of 2 year
|
Maximal inspiratory and expiratory muscle strength will be evaluated using mouth pressure device.
|
Trough study completion, an average of 2 year
|
|
Respiratory Muscle Endurance
Time Frame: Trough study completion, an average of 2 year
|
The test will be started at 30% of maximum inspiratory pressure and the inspiratory threshold load will be increased by 10% of the maximal inspiratory pressure value every two minutes.
New pressure loading will be maintained without removing the device from the mouth.
If the individual cannot breathe 3 consecutive times, the test will be terminated by the physiotherapist.
The total duration of the test and the maximum pressure value at which it continues to breathe for at least 1 minute will be multiplied.
The value found will be recorded as the respiratory muscle endurance value.
|
Trough study completion, an average of 2 year
|
|
Pulmonary function (Forced expiratory volume in the first second (FEV1))
Time Frame: Trough study completion, an average of 2 year
|
Pulmonary function will be evaluated with the spirometry.
Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria.
With the device, forced expiratory volume in the first second (FEV1) will be evaluated.
|
Trough study completion, an average of 2 year
|
|
Pulmonary function (Forced vital capacity (FVC))
Time Frame: Trough study completion, an average of 2 year
|
Pulmonary function will be evaluated with the spirometry.
Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria.
With the device, forced vital capacity (FVC) will be evaluated.
|
Trough study completion, an average of 2 year
|
|
Pulmonary function (FEV1/FVC)
Time Frame: Trough study completion, an average of 2 year
|
Pulmonary function will be evaluated with the spirometry.
Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria.
With the device, FEV1 / FVC will be evaluated.
|
Trough study completion, an average of 2 year
|
|
Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%))
Time Frame: Trough study completion, an average of 2 year
|
Pulmonary function will be evaluated with the spirometry.
Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria.
With the device, flow rate 25-75% of forced expiratory volume (FEF 25-75%) will be evaluated.
|
Trough study completion, an average of 2 year
|
|
Pulmonary function (Peak flow rate (PEF))
Time Frame: Trough study completion, an average of 2 year
|
Pulmonary function will be evaluated with the spirometry.
Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria.
With the device, peak flow rate (PEF) will be evaluated.
|
Trough study completion, an average of 2 year
|
|
Peripheral Muscle Strength
Time Frame: Trough study completion, an average of 2 year
|
Shoulder abduction and knee extensor muscle strength using portable hand held dynamometer will be evaluated.
|
Trough study completion, an average of 2 year
|
|
Trunk muscle endurance
Time Frame: Trough study completion, an average of 2 year
|
Trunk muscle endurance will be evaluated with the pelvic bridge test and partial sit-up test.
|
Trough study completion, an average of 2 year
|
|
Dyspnea
Time Frame: Trough study completion, an average of 2 year
|
Modified Borg Scale: The Modified Borg scale is a subjective scale that scores 0-10 for breathlessness and fatigue at rest and/or during activity. The lowest 0 points "not at all" the highest 10 points "very severe" means shortness of breath. The Modified Medical Research Council (MMRC) dyspnea scale will be used to determine the perception of dyspnea during activities of daily living. |
Trough study completion, an average of 2 year
|
|
Fatigue
Time Frame: Trough study completion, an average of 2 year
|
Fatigue will be assessed with Fatigue Severity Scale (Turkish version).
This scale includes 9 items and each item scores from 1 (strong disagreement) to 7 (strong agreement) point.
Fatigue Severity Scale total score is calculates by deriving an arithmetic mean.
Cut-score of over 4 means significant fatigue and higher score indicates more severe fatigue.
|
Trough study completion, an average of 2 year
|
|
Disease Specific Quality of Life
Time Frame: Trough study completion, an average of 2 year
|
Quality of life will be measured using Turkish version of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 version 3.0 (EORTCQLQ).
The cancer-specific questionnaire has 30 questions and incorporates five functional scales, three symptom scales, a global health status and several single items.
All item scores are transformed to 0-100.
Higher values indicate higher functional/health level in functional scales, a higher quality of life level in global health status and increased symptoms in symptom scales.
|
Trough study completion, an average of 2 year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Meral BOŞNAK GÜÇLÜ, Prof. Dr., Gazi University
- Study Chair: Gülsüm SERTTAŞ GÜVEN, MSc., Gazi University
- Principal Investigator: Ece BAYTOK, MSc., Gazi University
- Principal Investigator: Muhammet SAYAN, A. Prof. Dr, Gazi University
- Principal Investigator: Ali ÇELİK, Prof. Dr., Gazi University
Publications and helpful links
General Publications
- de Oliveira Vacchi C, Martha BA, Macagnan FE. Effect of inspiratory muscle training associated or not to physical rehabilitation in preoperative anatomic pulmonary resection: a systematic review and meta-analysis. Support Care Cancer. 2022 Feb;30(2):1079-1092. doi: 10.1007/s00520-021-06467-4. Epub 2021 Aug 21.
- Cooley ME. Symptoms in adults with lung cancer. A systematic research review. J Pain Symptom Manage. 2000 Feb;19(2):137-53. doi: 10.1016/s0885-3924(99)00150-5.
- Miserocchi G, Beretta E, Rivolta I. Respiratory mechanics and fluid dynamics after lung resection surgery. Thorac Surg Clin. 2010 Aug;20(3):345-57. doi: 10.1016/j.thorsurg.2010.03.001.
- Nomori H, Horio H, Fuyuno G, Kobayashi R, Yashima H. Respiratory muscle strength after lung resection with special reference to age and procedures of thoracotomy. Eur J Cardiothorac Surg. 1996;10(5):352-8. doi: 10.1016/s1010-7940(96)80094-7.
- Granger CL, McDonald CF, Irving L, Clark RA, Gough K, Murnane A, Mileshkin L, Krishnasamy M, Denehy L. Low physical activity levels and functional decline in individuals with lung cancer. Lung Cancer. 2014 Feb;83(2):292-9. doi: 10.1016/j.lungcan.2013.11.014. Epub 2013 Nov 26.
- Kocjan J, Gzik-Zroska B, Nowakowska-Lipiec K, Burkacki M, Suchon S, Michnik R, Czyzewski D, Adamek M. Thoracic surgery may alter body static balance via diaphragm dysfunction. PLoS One. 2022 Aug 31;17(8):e0273641. doi: 10.1371/journal.pone.0273641. eCollection 2022.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Gazi University 80
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Cancer
-
M.D. Anderson Cancer CenterRecruitingStage III Lung Cancer AJCC v8 | Lung Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingStage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; MedWaves, IncRecruitingLung Cancer | Lung Cancer Stage I | Lung Cancer Stage II | Stage I Lung Cancer | Stage I - II Primary Lung Cancer | Stage II Lung CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer... and other conditionsUnited States
-
WindMIL TherapeuticsBristol-Myers SquibbTerminatedNSCLC | Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer MetastaticUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingCaregiver | Stage III Lung Cancer AJCC v7 | Stage I Lung Cancer AJCC v7 | Stage II Lung Cancer AJCC v7 | Stage IB Lung Cancer AJCC v7 | Stage IA Lung Cancer AJCC v7 | Stage IIA Lung Cancer AJCC v7 | Stage IIB Lung Cancer AJCC v7 | Stage IIIA Lung Cancer AJCC v7 | Stage IIIB Lung Cancer AJCC v7United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedStage IV Lung Cancer | Stage III Lung Cancer | Stage I Lung Cancer | Stage II Lung CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung... and other conditionsUnited States
-
Emory UniversityNational Cancer Institute (NCI)TerminatedLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
University of California, San FranciscoMerck Sharp & Dohme LLCWithdrawnLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
Clinical Trials on Functional inspiratory muscle training group
-
Istinye UniversityCompletedStroke | Respiratory MusclesTurkey
-
Ceren Derya GültekinRecruitingPulmonary Rehabilitation | Inspiratory Muscle Training | Hematopoietic Stem Cell Transplantation (HSCT)Turkey
-
Selcuk UniversityNot yet recruitingMultiple Sclerosis | Respiratory Muscles | Core Muscles | Functional Inspiratory Muscle TrainingTurkey
-
Saglik Bilimleri UniversitesiCompletedChronic Obstructive Pulmonary Disease (COPD)Turkey (Türkiye)
-
University of YalovaRecruitingChronic Obstructive Pulmonary DiseaseTurkey (Türkiye)
-
Elif KabasakalRecruitingBronchiectasis | Functional Inspiratory Muscle TrainingTurkey (Türkiye)
-
Hacettepe UniversityCompleted
-
Universidad Complutense de MadridColegio Profesional de Fisioterapeutas de la Comunidad de Madrid, Madrid,...CompletedQuality of Life | Covid19 | Respiratory Muscle Training | Respiratory Function Test | Psychosocial FactorSpain
-
Dokuz Eylul UniversityUnknown